The Patent Finder

Pharmaceutical Composition For The Treatment Of Pulmonary Arterial Hypertension

Actelion Pharmaceuticals Ltd

A patent family: one line of work, grouped by real continuity rather than by a technology label inferred from titles. 2 of these applications claim priority to application PCT/EP2019/086754, filed Dec 20, 2019. A shared origin can cover several different claimed inventions, which is why members here may not share a title. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleHolderStatusExpiresPatent lifetimeUsedRemainingConfidence
US 11,234,980Pharmaceutical Composition For The Treatment Of Pulmonary Arterial Hypertension
In force
 · High confidence
UsedRemaining
Actelion Pharmaceuticals Ltd.In forceHigh confidence
US 11,464,777Pharmaceutical Composition For The Treatment Of Pulmonary Arterial Hypertension
In force
 · Low confidence
Actelion Pharmaceuticals LtdIn forceLow confidence
Application 17/953,530Pharmaceutical Composition For The Treatment Of Pulmonary Arterial Hypertension
Abandoned
Abandoned Jun 17, 2024
Actelion Pharmaceuticals LtdAbandonedAbandoned Jun 17, 2024
3 of 3 records shown. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
2 of these are in force and held by Actelion Pharmaceuticals Ltd.
Updated Nov 19, 2026 · includes USPTO assignment data published Nov 18, 2026, status data published Nov 19, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 19, 2026 · includes USPTO assignment data published Nov 18, 2026, status data published Nov 19, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited